Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

Elie Azoulay¹, Philippe R Bauer², Eric Mariotte³, Lene Russell⁴, Paul Knoebl⁵, Ignacio Martin-Loeches⁶, Frédéric Pène⁷, Kathryn Puxty⁸, Pedro Povoa^{9

10

11}, Andreas Barratt-Due¹², Jose Garnacho-Montero¹³, Julia Wendon¹⁴, Laveena Munshi¹⁵, Dominique Benoit¹⁶, Michael von Bergwelt-Baildon^{17

18}, Marco Maggiorini¹⁹, Paul Coppo²⁰, Spero Cataland²¹, Agnès Veyradier²², Andry Van de Louw²³; Nine-i Investigators

Affiliations

¹ Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France. elie.azoulay@aphp.fr.
² Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
³ Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France.
⁴ Department of Intensive Care, Copenhagen University Hospital, RigshospitaletCopenhagen Academy for Medical Simulation and Education, University of Copenhagen, and the Capital Region of Denmark, Copenhagen, Denmark.
⁵ Division of Hematology and Hemostasis Department of Medicine 1, Medical University of Vienna, Vienna, Austria.
⁶ Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St. James's Hospital, St James Street, Dublin 8, Ireland.
⁷ Centre National Maladie Rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, Cochin Hospital and Paris University, Paris, France.
⁸ Department of Intensive Care, Glasgow Royal Infirmary, Glasgow, UK.
⁹ Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Lisbon, Portugal.
¹⁰ NOVA Medical School, New University of Lisbon, Lisbon, Portugal.
¹¹ Center for Clinical Epidemiology and Research, Unit of Clinical Epidemiology, Odense University Hospital Odense, Odense, Denmark.
¹² Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
¹³ Intensive Care Clinical Unit, Hospital Universitario Virgen Macarena, Seville, Spain.
¹⁴ King's College Hospital, London, UK.
¹⁵ Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
¹⁶ Ghent University Hospital, Ghent, Belgium.
¹⁷ Intensive Care in Hematologic and Oncologic Patients, Munich, Germany.
¹⁸ Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany.
¹⁹ Medical Intensive Care Unit, University Hospital of Zurich, Zurich, Switzerland.
²⁰ Centre National Maladie Rare des Microangiopathies Thrombotiques, Service d'Hématologie, Saint-Antoine Hospital and Paris University, Paris, France.
²¹ Department of Medicine, Ohio State University, Columbus, OH, USA.
²² Centre National Maladies Rares des Microangiopathies Thrombotiques, Service d'Hématologie, Lariboisière Hospital and Paris University, Paris, France.
²³ Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA.

PMID: 31965263
DOI: 10.1007/s00134-019-05904-7

Free article

Published Erratum

Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

Elie Azoulay et al. Intensive Care Med. 2020 Mar.

Free article

. 2020 Mar;46(3):570-571.

doi: 10.1007/s00134-019-05904-7.

Authors

Affiliations

¹ Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France. elie.azoulay@aphp.fr.
² Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
³ Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France.
⁴ Department of Intensive Care, Copenhagen University Hospital, RigshospitaletCopenhagen Academy for Medical Simulation and Education, University of Copenhagen, and the Capital Region of Denmark, Copenhagen, Denmark.
⁵ Division of Hematology and Hemostasis Department of Medicine 1, Medical University of Vienna, Vienna, Austria.
⁶ Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St. James's Hospital, St James Street, Dublin 8, Ireland.
⁷ Centre National Maladie Rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, Cochin Hospital and Paris University, Paris, France.
⁸ Department of Intensive Care, Glasgow Royal Infirmary, Glasgow, UK.
⁹ Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Lisbon, Portugal.
¹⁰ NOVA Medical School, New University of Lisbon, Lisbon, Portugal.
¹¹ Center for Clinical Epidemiology and Research, Unit of Clinical Epidemiology, Odense University Hospital Odense, Odense, Denmark.
¹² Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
¹³ Intensive Care Clinical Unit, Hospital Universitario Virgen Macarena, Seville, Spain.
¹⁴ King's College Hospital, London, UK.
¹⁵ Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
¹⁶ Ghent University Hospital, Ghent, Belgium.
¹⁷ Intensive Care in Hematologic and Oncologic Patients, Munich, Germany.
¹⁸ Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany.
¹⁹ Medical Intensive Care Unit, University Hospital of Zurich, Zurich, Switzerland.
²⁰ Centre National Maladie Rare des Microangiopathies Thrombotiques, Service d'Hématologie, Saint-Antoine Hospital and Paris University, Paris, France.
²¹ Department of Medicine, Ohio State University, Columbus, OH, USA.
²² Centre National Maladies Rares des Microangiopathies Thrombotiques, Service d'Hématologie, Lariboisière Hospital and Paris University, Paris, France.
²³ Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA.

PMID: 31965263
DOI: 10.1007/s00134-019-05904-7

Abstract

The original version of this article unfortunately contained a mistake. The penultimate row of Table 4 shows INR > 1.5 which is incorrect. The correct figure is INR < 1.5. The authors apologize for the mistake. The correct table is given below.

PubMed Disclaimer

Erratum for

Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.
Azoulay E, Bauer PR, Mariotte E, Russell L, Knoebl P, Martin-Loeches I, Pène F, Puxty K, Povoa P, Barratt-Due A, Garnacho-Montero J, Wendon J, Munshi L, Benoit D, von Bergwelt-Baildon M, Maggiorini M, Coppo P, Cataland S, Veyradier A, Van de Louw A; Nine-i Investigators. Azoulay E, et al. Intensive Care Med. 2019 Nov;45(11):1518-1539. doi: 10.1007/s00134-019-05736-5. Epub 2019 Oct 7. Intensive Care Med. 2019. PMID: 31588978

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Andalusian Health Repository - access to free full text
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

Affiliations

Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources